STOK : Stoke Therapeutics stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 9 Wall Street analysts offering Stoke Therapeutics stock forecast in the last 6 months have average price target of $60.89 with a high forecast of $76.0 and a low forecast of $49.0. The average Stoke Therapeutics stock forecast represents a 99.38% increase from the last price of $30.54. From AI system, total return is 2038.92% from 1618 forecasts. For Stoke Therapeutics stock forecast 2021, 8 predictions are offered for each month of 2021 with average Stoke Therapeutics stock forecast of $36.71, a high forecast of $39.71, and a low forecast of $31.35. The average Stoke Therapeutics stock forecast 2021 represents a 20.19% increase from the last price of $30.54. For Stoke Therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average Stoke Therapeutics stock forecast of $42.07, a high forecast of $43.86, and a low forecast of $39.72. The average Stoke Therapeutics stock forecast 2022 represents a 37.77% increase from the last price of $30.54. For Stoke Therapeutics stock forecast 2025, 12 predictions are offered for each month of 2025 with average Stoke Therapeutics stock forecast of $43.92, a high forecast of $44.04, and a low forecast of $43.7. The average Stoke Therapeutics stock forecast 2025 represents a 43.8% increase from the last price of $30.54. For Stoke Therapeutics stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Stoke Therapeutics stock forecast of $42.54, a high forecast of $43.73, and a low forecast of $41.0. The average Stoke Therapeutics stock forecast 2026 represents a 39.31% increase from the last price of $30.54. For Stoke Therapeutics stock forecast 2030, 12 predictions are offered for each month of 2030 with average Stoke Therapeutics stock forecast of $38.08, a high forecast of $38.96, and a low forecast of $37.19. The average Stoke Therapeutics stock forecast 2030 represents a 24.7% increase from the last price of $30.54. For Stoke Therapeutics stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Stoke Therapeutics stock forecast of $37.13, a high forecast of $37.15, and a low forecast of $37.11. The average Stoke Therapeutics stock forecast 2031 represents a 21.57% increase from the last price of $30.54. Please, see more forecasts below.